AMARIN CORP PLC\UK Increase (Decrease) in Other Operating Assets
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Other Operating Assets of $1.25 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2011-11-08
- AMARIN CORP PLC\UK increase (decrease) in other operating assets for the quarter ending 2011-09-30 was $1.08M.
- AMARIN CORP PLC\UK increase (decrease) in other operating assets for the quarter ending 2010-09-30 was -$83.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2011-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.25M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $172.00K 10-Q · filed 2011-08-09 | ||
| 2010-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$1.25M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | -$1.17M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |